GMI Calculator (Glucose Management Indicator)

Calculate your Glucose Management Indicator (GMI) in both NGSP-aligned % and IFCC-equivalent mmol/mol from your continuous glucose monitor (CGM) mean glucose using the published Bergenstal et al. (2018) formula.

GMI: 6.9% (52 mmol/mol)
Unrounded Bergenstal (2018) output: 6.8980% · Mean glucose: 150 mg/dL (8.3 mmol/L)

How to Use This Calculator

  1. Select your mean glucose unit (mg/dL or mmol/L).
  2. Enter the mean glucose reported on your CGM summary (typically over 14 or more days).
  3. Optionally enter the number of sensor days to check data sufficiency.

Formula and Units

Equation Summary: GMI (%) = 3.31 + 0.02392 × [mean glucose in mg/dL]; GMI (mmol/mol) = (GMI (%) − 2.152) / 0.09148

Published by Bergenstal et al. (Diabetes Care 2018): GMI (%) = 3.31 + 0.02392 × [mean glucose in mg/dL]. When mean glucose is entered in mmol/L, it is first converted to mg/dL via mg/dL = mmol/L × 18.0182, which is equivalent to GMI (%) = 3.31 + 0.430995 × [mean glucose in mmol/L]. Companion IFCC equivalent: GMI (mmol/mol) = (GMI (%) − 2.152) / 0.09148.

Supported Units: mg/dL, mmol/L, % (GMI), mmol/mol (IFCC equivalent)

Worked Example

For a 14-day CGM mean glucose of 150 mg/dL: GMI (%) = 3.31 + 0.02392 × 150 = 3.31 + 3.588 = 6.898% (displayed as 6.9%, or 51.9 mmol/mol, displayed as 52 mmol/mol). Note that the ADAG eAG equation at 150 mg/dL yields 6.85% — demonstrating why GMI and eAG use distinct regression slopes.

Understanding the Result

GMI provides a standardized CGM metric that estimates what a laboratory A1C would be on average for a given CGM mean glucose level.

GMI vs Lab HbA1c

GMI and laboratory HbA1c are calculated from different biological signals. GMI is derived strictly from interstitial glucose concentration measured by a CGM sensor (typically over 10–14+ days), whereas lab HbA1c reflects red blood cell glycation over 8–12 weeks. Because red blood cell lifespan, glycation rates, and recent glucose shifts vary between individuals, a person’s GMI can be consistently higher or lower than their laboratory HbA1c.

Limitations

  • GMI is designed for continuous glucose monitoring datasets (typically 10–14+ days with >=70% active sensor time).
  • A mean of sparse fingerstick readings (for example, only morning fasting tests) does not represent true 24-hour mean glucose and should not be treated as a true CGM GMI.

Related Tools

A1C to eAG Calculator

Translate laboratory NGSP HbA1c (%) into estimated average glucose (eAG) in both mg/dL and mmol/L using the Nathan et al. (2008) ADAG linear regression equation.

HbA1c Unit Converter (mmol/mol ↔ %)

Convert laboratory HbA1c results between IFCC standard units (mmol/mol, used in the UK, Europe, and Australia) and NGSP/DCCT percentage units (%, used in the US and Canada) using the published NGSP/IFCC master equation.

Glucose Variability Calculator (CV% & SD)

Paste a list of glucose readings (separated by commas, spaces, or newlines) to compute arithmetic mean, population standard deviation (SD), coefficient of variation (CV%), min/max, and count of entered readings within your selected target range.

Related Practical Guides:

Frequently Asked Questions

Why is my GMI 6.9% at 150 mg/dL while the A1C-to-eAG table says 7.0% is 154 mg/dL?

Bergenstal et al. (2018) derived GMI from modern CGM trials with a different intercept (3.31) and slope (0.02392) than the older 2008 ADAG study.

How many days of CGM data are recommended for GMI?

Clinical consensus reports (such as the Ambulatory Glucose Profile / AGP) generally recommend at least 10 to 14 days of CGM data.

Sources and Review Information

  • [S11] Bergenstal RM, Beck RW, Close KL, et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care. 2018;41(11):2275-2280. Reference Source
  • [S10] NGSP / IFCC Master Equation: Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes. Clin Chem. 2004;50(1):166-174. Reference Source

Prepared by: GlucoBP Editorial & Engineering Team · Verification status: Formula verified against published reference; clinical review pending · Last updated: 2026-11-15